Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
ConclusionsPP3M was more effective than OAs and monthly LAIs in improving clinical outcomes for patients with schizophrenia in a real-world setting in Spain.
Source: CNS Drugs - Category: Neurology Source Type: research
More News: Abilify | Electronic Medical Records (EMR) | Emergency Medicine | Invega | Invega Sustenna | Neurology | Primary Care | Psychiatry | Schizophrenia | Spain Health | Study